Client
- Description
- Comprehensive pharmaceutical provider
- Location
- District of Columbia · United States of America
Registrant
- Firm
- THE WALTER GROUP
- Description
- Lobbying on behalf of client
- Location
- Alexandria, Virginia, United States of America
Lobbying activities
4 issuesTaxation/Internal Revenue Code
Repeal of LIFO (last-in, first-out).
LobbyistsJEFFERY WALTER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
HR 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Oncology Innovation Project - Center for Medicare and Medicaid Innovation. Sequestration cuts to cancer care. HR 1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.
LobbyistsJEFFERY WALTER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
HR 800 & S. 806 (Medicare Prompt Pay discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. HR 1416 Caner Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. HR 1919, HR 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding Legislation pertaining to drug manufacturing shortages.
